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ABSTRACT 
Experiment 1; Chick embryos received a single DFP 
ex p o s ure (0, 50, 100, 200, 400, 800, 1600, 3200 ]ig/kg) on 
embryogenesis day (E) 11. DFP was fatal to all embryos at 
400 pg/kg and above, but did not affect hatch success at 
lower doses. Prenatal DFP reduced hatch weight and 
increased weight by posthatch day (PHD) 14. Prenatal DFP 
produced sex- and dose-dependent changes in distress 
vocalizations (DVs), but not activity on PHD 1. DFP 
increased tonic immobility duration (TI) on PHD 14. DFP 
increased lipopolysaccharide-induced lymphocyte 
proliferation in blood harvested on PHD 16 in females. 
Experiment 2: Daily DFP (0, 50, 100, or 200 pg/kg) on E 
10-12 reduced hatch success. DFP reduced hatch weights in 
males, but not females. Prenatal DFP, 200 pg/kg, increased 
weight by PHD 14. DFP did not affect DVs, but increased 
activity in males at 50 pg/kg and females at 100 ug/kg on 
PHD 1. DFP increased TI in females, but not males, on PHD 
14. DFP decreased pokeweed mitogen-induced and increased 
lipopolysaccaride-induced lymphocyte proliferation in blood 
and thymus (respectively) harvested on PHD 16. 
Experiment 3; Daily DFP (0, 100, or 200 iig/kg) on E 10-
12 reduced hatch success, but did not affect weight at hatch 
or PHD 14. Chicks received 0.0, 0.5, or 1.5 mg/kg 
scopolamine 30 min before behavioral tests. Prenatal DFP 
vi 
(100 pg/kg) decreased DVs and 1.5 mg/kg scopolamine reversed 
the effect on PHD 1; there were no activity effects. 
Scopolamine, 0.5 mg/kg reduced TI except at 200 ug/kg DFP on 
PHD 14. 
Experiment 4: Daily DFP (0, 150, or 200 ] i g / k g )  on E 10-
12 did not affect hatch success or hatch weight, but 
increased weight by PHD 14. Chicks received 0.0, 0.25, or 
0.5 mg/kg physostigmine 30 min before behavioral tests. On 
PHD 1, 0.25 physostigmine increased DVs in chicks at 150 
Vig/kg DFP; activity was not affected. DFP increased TI in 
females, but not males, and PHY increased TI in females at 0 
Vig/kg DFP on PHD 18. 
These data demonstrate perinatal consequences of 
prenatal DFP that endure into the third week posthatch and 
are sensitive to cholinergic manipulation. 
1 
INTRODUCTION 
Organophosphate (OP) pesticides are among the most 
toxic and widely used pesticides in the world (Mearns, Dunn, 
& Lees-Haley, 1994; Michalek & Pintor, 1990; Overstreet & 
Schiller, 1992). In 1983, OPs poisoned 2 million people 
worldwide and resulted in 40 thousand deaths (Mearns et al., 
1994). The current widespread use of OP in agriculture 
provides for direct exposure of production workers, 
applicators, and field workers. A much wider population is 
at risk for low level exposure through food and drinking 
water that contain OP residues (Mearns et al., 1994; 
Michalek & Pintor, 1990; Overstreet & Schiller, 1992). 
An extensive literature exists describing the effects 
of acute OP poisoning in adult organisms. Organophosphates 
alter neurotransmission in cholinergic systems and affect 
both behavioral and immune system responses (Mearns et al., 
1994). Considerably less investigation has focused on the 
developmental effects of low level OP exposure. In 
particular, little is known of possible perinatal effects of 
prenatal OP exposure. Maternal exposure to various 
environmental pollutants during embryogenesis can adversely 
affect perinatal behavior of offspring (Michalek & Pintor, 
1990). Behavioral changes occur in offspring at doses that 
do not produce overt maternal behavioral or physiological 
indications (Hughes, Belser, & Brett, 1975). 
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Characterization of perinatal and postnatal consequences of 
low level OP exposure is an important consideration in the 
development of strategies designed to prevent and mitigate 
adverse effects of OP neurotoxicity. 
Organophosphates can enter the body via inhalation, 
ingestion, or transdermal absorption (Mearns et al., 1994, 
Michalek & Pintor, 1990). Organophosphates increase 
concentrations of the neurotransmitter acetycholine (ACh) in 
the synaptic cleft by inhibiting acetylcholinesterase 
(AChE). Acetylcholinesterase degrades ACh released at 
synapses, terminating its activity (Feldman, Meyer, & 
Quenzer, 1997; Rang, Dale, Ritter, & Gardner, 1995) . A 
nxmber of OP compounds (e.g., diisopropyl fluorophosphate, 
parathion, soman) irreversibly inhibit the activity of AChE 
by phosphorylating the enzyme (Feldman et al. 1997; 
Overstreet & Schiller, 1992). Although OPs slowly 
dissociate from AChE, recovery of enzyme function depends on 
new synthesis, a process that can take weeks (Feldman et 
al., 1997; Rang et al., 1995). Inhibition of the enzyme 
results in excessive amounts of ACh and prevents 
repolarization of the membrane of the postsynaptic cell 
(Michalek & Pintor, 1990) . The apparent irreversibility of 
AChE inhibition by OPs (Overstreet & Schiller, 1992) 
presents a potential for cumulative developmental effects of 
low level pre- and perinatal OP exposure. 
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The distribution of cholinergic neurons and receptors 
throughout the nervous and immune systems suggests a 
potential for a wide array of OP poisoning effects. 
Cholinergic synapses are found peripherally at neuromuscular 
junctions and in the autonomic nervous system, and centrally 
in the basal forebrain, reticular formation, striatum, and 
hippocampus (Fibiger & Vincent, 1987). Additionally, 
cholinergic receptors and/or AChE have been found in 
abundance in the spleen, thymus, lymph nodes, and other 
lymphoid accumulations (Felten & Felten, 1991). 
Onset of symptoms associated with acute OP poisoning 
occurs within 4 to 8 hours and can endure for several weeks. 
Physical effects of mild OP intoxication include nausea, 
vomiting, abdominal pain, numbness in the extremities, 
fatigue, headaches, excessive salivation, and diarrhea. 
Victims of moderate intoxication experience more intense 
manifestation of the above symptoms accompanied by 
generalized weakness, constriction of pupils, and muscle 
spasms. Severe intoxication may result in blurred vision, 
unconsciousness, paralysis, respiratory depression, and 
death. Psychological effects associated with OP poisoning 
include cognitive impairment (e.g., memory, concentration, 
and visuospatial information processing deficits), anxiety, 
depression, irritability, and restlessness (Mearns et al., 
1994) . 
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Cognitive impairments have been demonstrated not only 
in individuals suffering acute OP poisoning, but also in 
otherwise symptom-free individuals. Farmers and pesticide 
applicators routinely exposed to OPs scored significantly 
higher on the Taylor Manifest Anxiety scale than matched 
controls (Mearns et al., 1994, Levin et al., 1976). In a 
1992 study, 21 migrant farm workers that were twice 
poisoned, 1 and 5 years prior to the study, scored lower on 
motor speed and visuospatial memory and higher on anxiety 
than did controls (Mearns et al., 1994, Reidy et al., 1992). 
Individuals poisoned an average of 9 years prior to testing 
exhibited a higher incidence of depression and poorer 
performance on the three-pairs-of-items memory test. 
Subjects also scored higher on the Minnesota Multiphasic 
Personality Inventory (MMPI) validity scales for paranoia 
and introversion. The results of studies reporting human 
cognitive impairments suffer from confounding factors such 
as involvement in litigation (a possible source of anxiety), 
determination of exposure doses, and absence of blind 
evaluation procedures. Controlled laboratory studies using 
animal models found cognitive impairments similar to those 
reported in humans. Rats that received daily exposure to 
OPs for 14 days exhibited spatial memory impairment and 
downregulation of central muscarinic ACh receptors. Male 
rats showed impairment of behaviors correlated with 
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emotional responses after chronic OP administration 
(Wolthuis, Phileppens/ & Vanwersch, 1991). A literature 
search revealed little information regarding effects of 
prenatal OP exposure on perinatal behavior. 
Organophosphate exposure also alters immune system 
responses in adults. Interleuken 2 (IL2) signaling is 
disrupted by OP pesticide exposure. Organophosphates 
inhibit IL2-dependent proliferation of human natural killer 
(NK) cells, mouse CTLL2 cells, and enhancement of target 
cell killing by human NK cells in vitro (Casale, 
Vennerstrom, Bavari, & Wang, 1993). Also, human bone marrow 
cells exposed to active OP metabolites in vitro showed dose-
dependent suppression of colony formation by erythrocytes 
and granulocyte-macrophage progenitors (Gallicchio, Casale, 
& Watts, 1987). Depression of hematopoiesis of lymphoid and 
myeloid cells would be expected to compromise 
immunoreactivity in response to an immunogenic challenge. 
This evidence suggests that OP-induced alteration of 
immunoreactivity could result in a greater susceptibility to 
infectious diseases and cancer. A literature search yielded 
no information regarding prenatal OP effects on perinatal 
immune system function. 
There is an extensive literature describing adverse 
embryo morphological and physiological effects of OP 
exposure. The first report of hiiman malformation associated 
6 
with prenatal OP exposure involved a pregnant (4 weeks) farm 
worker who was among 35 workers poisoned by OPs (Romero, 
Barnett, & Midtling, 1989). At birth the female infant 
exhibited brain atrophy, multiple cardiac defects, facial 
anomalies, and died after 14 days. There was no family 
history of birth defects. Human fetal brains (8-10 weeks) 
exposed to OP in vitro exhibited inhibition of AChE 
(Banerjee, Ghosh, Mitra, & Bhattacharya, 1991) . A study of 
cultured chick dorsal root ganglia demonstrated that OP 
significantly altered cell morphology and cell membrane 
integrity (Tuler & Bowen, 1989). An in vivo study of 
prenatal OP exposure in chicks demonstrated perinatal ataxia 
(Farage-Elawar & Francis, 1988). Physical anomalies 
(tibiotarsal angulations and poor feathering) were observed 
on day 17 of inciibation in chicks exposed in ovo to OP on 
day 3 of incubation (Uyeki, Doull, Cheng, & Misawa, 1982) . 
In vitro studies have demonstrated increased sensitivity of 
muscle tissue to AChE inhibitors and downregulation of 
muscarinic ACh receptors. These more subtle effects have 
occurred in the absence of overt behavioral indications of 
OP poisoning (Melcheres & Van Helden, 1990) . These data 
suggest that pregnant women exhibiting no overt behavioral 
effects of OP poisoning might have physiologically 
significant levels of OP contamination that could adversely 
affect fetal development. 
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The present study was designed to examine perinatal 
consequences of prenatal OP exposure in a precocial avian 
species. Precocial domestic fowl chicks are particularly 
well suited for perinatal behavioral evaluation independent 
of maternal confounds (Rogers, 1995); i.e., the eggs and not 
the hen are exposed. The embryology of domestic fowl is 
well defined due to its widespread use in developmental 
biology. The extensive embryological data-base makes the 
chick embryo an excellent model for toxicity screening. 
Chemicals have been injected into embryos as early as day 0 
and as late as day 15 of incubation. Additionally, the 
chicken model is preferred over rodent models regarding the 
clinical signs of OP poisoning. The chicken model better 
reflects the diverse central and peripheral effects of OPs 
induced in humans than do rodent models (Farage-Elawar & 
Francis, 1988) . The current study was designed to 
investigate perinatal effects of prenatal exposure to an OP, 
diisopropyl fluorophosphate (DFP), using the chick model. 
Our laboratory has previously studied behavioral effects of 
prenatal methyl mercury (Hughes, Belser, & Brett, 1975), and 
more recently effects of prenatal cocaine on perinatal 
behavior and immune system function in domestic fowl 
(Cunnick et al., 1994; Hughes et al., 1994a; Hughes et al., 
1994b). Cocaine injected into the airspace of fertile eggs 
at the midpoint of embryogenesis altered perinatal social 
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(activity and isolation-induced vocalizations) and defensive 
behaviors (tonic immobility), as well as immunoreactivty to 
an immunogenic challenge (Hughes et al., 1994a; Hughes et 
al., 1994b). 
Administration of DFP during embryogenesis might also 
reveal alterations in these responses. Exposure to OPs 
alter cholinergic systems (Feldman et al., 1997; Rang et 
al., 1995). In the present study, prenatal DFP effects on 
perinatal activity and distress vocalizations (DVs) were 
evaluated during a 5-min isolation period on posthatch day 
(PHD) 1 and on a tonic immobility (TI) test on PHD 14. 
Acute OP poisoning produces anxiety in humans that is 
evident up to 5 years after exposure (Mearns et al., 1994; 
Levin et al., 1976). The activity and distress 
vocalizations (DVs) measures were chosen because social 
stress alters these responses in chicks. Chicks imprint on 
cohorts shortly after hatching. Social isolation is 
stressful for chicks and DVs are an index of stress 
(Fullerton, Berryman, & Slutkin, 1959; Panksepp, Herman, 
Conner, Bishop, & Scott, 1978; Sufka & Hughes, 1991) . In 
addition to the stress-induced effects, activity in chicks 
is also sensitive to cholinergic manipulation. Cholinergic 
agonists decrease and antagonists increase activity during 
open field behavior (Genty, Faure, & Mills, 1985; Ksir, 
1978; Sanberg, 1983). 
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The tonic immobility (TI) response is a state of 
somatic immobility induced by brief physical restraint 
(Pestrude, 1977; Gallup, 1977). This TI response is 
sensitive to cholinergic manipulation (Gallup et al., 1983; 
Hatton, Tankle, Lanthorn, & Meyer, 1978; Hicks, 1976; 
Hughes, 1982; Meyer, 1975; Thompson, Piroch, Fallen, Hatton, 
1974; Woodruff, 1976) and has been observed in a wide 
variety of invertebrate (Ratner, 1977) and vertebrate 
(Pestrude, 1977) species. When an animal is physically 
restrained it will struggle briefly and then become 
immobile. The immobile posture persists after restraint is 
terminated for a period of minutes to hours (Gallup, 1977). 
Tonic immobility is thought to be an adaptive response by 
prey during a predatory encounter. Struggling and 
vocalizing by prey are important stimuli for maintenance of 
a predatory attack. Attack behaviors of predators are 
inversely related to the duration of immobility of prey 
(Thompson, Foltin, Boylan, Sweet, Graves, & Lowitz, 1981; 
Gallup, Boren, Suarez, Wallnau, 1983) . Gallup (1977) 
characterizes tonic immobility as a fear response. Humans 
exhibit similar behavior associated with rape-induced 
paralysis (Suarez & Gallup, 1979) and catatonic 
schizophrenia (Maser & Gallup, 1974) . 
Behavioral manipulations that induce fear increase 
immobility duration and those that attenuate fear reduce TI 
10 
duration. Immobility duration is enhanced by predatory 
encounters (including exposure to humans as potential 
predators), simulated predatory encounters (e.g., a stuffed 
hawk, artificial eyes), loud noises, electric shock, 
suspension over a visual cliff, and conditioned aversive 
stimuli (Gallup, 1977). Habituation to induction, handling, 
conditioned safety cues, and tranquilizer administration 
decrease immobility duration (Crawford, 1977; Gallup, 1977; 
Gallup et al., 1983; Thompson, 1977), 
Tonic immobility is sensitive to manipulation of 
neurotransmitter systems other than the cholinergic system. 
Drugs that alter monoaminergic (Gallup et al., 1983; Maser, 
Gallup, & Hicks, 1975; Hughes, 1985; Thompson & Joseph, 
1978) and opioid (Wallnau & Gallup, 1979; Peters & Hughes, 
1978) activity also alter immobility duration to varying 
degrees. The strongest evidence for monoaminergic 
involvement implicates serotonergic mechanisms of tonic 
immobility (Gallup et al., 1983). Centrally administered 
serotonin (5-HT) agonists increase and antagonists decrease 
immobility duration in chickens (Boren, Gallup, Suarez, 
Wallnau, & Gagliardi, 1979; Gallup et al., 1983; Gallup & 
Wallnau, 1977; Hatton, Tankle, Lanthorn, & Meyer, 1978) and 
have opposite effects in rabbits (Hatton, Woodruff, & Meyer, 
1975) . 
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Cholinergic manipulations exhibit the same avian-
mammalian reversal of effects. Physostigmine (Gallup et 
al., 1983; Thompson et al., 1974) and pilocarpine (Sanberg, 
1983), cholinergic agonists, potentiate TI in chickens and 
ducks and attenuate TI in rabbits and guinea pigs (Hatton et 
al., 1975; Woodruff, Hatton, Frankl, & Meyer, 1976). 
Cholinergic antagonists (e.g., scopolamine, atropine) 
decrease immobility duration in these avian species (Hicks, 
1976; Hennig, Mclntyre, Moriarity, & Picerno, 1988; Hughes, 
1982; Thompson et al., 1974) and enhance TI in mammals 
(Hatton et al., 1975; Woodruff et al., 1976). Further, 
cholinergic manipulation of TI is mediated by central 
muscarinic mechanisms (Thompson et al., 1974). Scopolamine 
and atropine, both muscarinic receptor antagonists, 
attenuate TI in chickens, but their methyl analogs, which 
act only peripherally, do not (Hughes, 1982; Thompson et 
al., 1974). Cholinergic antagonists have similar effects on 
locomotor behavior. Scopolamine decreased locomotor 
behavior in chickens (Ksir, 1978; Sanberg, 1983) and rats 
(Sanberg, Pisa, & Fibiger, 1981). Atropine decreased open 
field behavior of chicks (Genty et al., 1985) . 
Because there has been little research on postnatal 
effects of prenatal DFP exposure, it is difficult to predict 
the direction of behavioral effects in this model. Drugs 
often have opposite effects depending on variables such as 
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dose and time course, as well as age and physiological state 
of the organism. However, given the known effects of 
cholinergic activity on tonic immobility in chicks and the 
potentiation of acetylcholine by DFP, some tentative 
predictions can be made. Diisopropyl fluorophosphate 
increases cholinergic concentrations by irreversibly 
inhibiting AChE. Cholinergic neurons are present in chicken 
embryos by embryological day (E) 7 (Rogers, 1995). Normal 
nervous system development depends on appropriate levels of 
embryonic neural activity. Prenatal exposure to DFP would 
be expected to increase embryonic cholinergic activity and 
might ultimately alter activity-dependent central nervous 
system development. If prenatal DFP-induced potentiation of 
cholinergic activity persists into postnatal life, tonic 
immobility duration in exposed chicks should be enhanced 
compared to controls. Similarly, locomotor activity in 
exposed chicks should be inhibited by prenatal DFP exposure. 
Because cholinergic mechanisms have not been implicated in 
control of vocalizations, prediction of prenatal DFP effects 
would be speculative. However, DVs are negatively 
correlated with activity during isolation. Therefore, if 
prenatal DFP decreases activity during isolation, DVs might 
be expected to increase (Sufka & Hughes, 1991). 
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EXPERIMENT 1 
The purpose of this experiment was to determine DFP 
dose parameters and possible sex differences in hatch 
success. Additionally, behavioral and immunological effects 
of prenatal DFP were evaluated for those treatment groups in 
which sufficient chicks hatched and survived (longer than 3 
days). The responses (DVs, activity changes, TI, and 
immunoreactivity) evaluated in this study are considered 
adaptive responses. 
Diisopropyl fluorosphate in sterile saline vehicle (0, 
50, 100, 200, 400, 800, 1600, or 3200 mg/kg; n = 30 per 
cell) was injected into the airspace of fertile eggs on E 
11. Day 11 is the midpoint of embryogenesis and was chosen 
because it corresponds to a period of rapid central nervous 
system (Romanoff, 1960) and immune system (Sharma, 1991) 
development in this species. 
Method 
Subjects 
Fertile White Leghorn eggs (n=240) were obtained from 
Hyline Inc., Dallas Center, lA. Upon hatch, chicks (N=80) 
were housed in46x26x31cm opaque plastic cages (n=6-7 
per cage) with floors and lids constructed of 2x2 hardware 
cloth. The colony room was maintained at a temperature of 
32.0 ± 1.0 ®C during the first week, and at 29.0 ± 1.0 °C, 
thereafter. Overhead fluorescent lights provided continuous 
14 
illumination. Food (Broiler Ration 3281-18C Medicated, 
Master Mix Poultry Feed/ Fort Wayne, IN) and water were 
available ad lib. 
Apparatus 
Incubation. Incubation of eggs occurred in a dark 
forced air incubator (model 1202, G.Q.F. Manufacturing, 
Savannah, GA) equipped with an electronic thermostat-
regulated heating element, an electronic 
thermometer/hygrometer, an automatic egg turner, and a 
capacity of 270 chicken eggs. The incubator was maintained 
at 38.0 ± 0.5 °C and 56% relative humidity. Chicks were 
hatched (last 3 days of incubation) in an incubator 
identical to the one above but without an egg turner (model 
1250, G.Q.F. Manufacturing, Savannah, GA) maintained at 37.0 
± 0.5 °C and 66% relative humidity. 
Isolation. Two test units (38 x 21 x 16 cm) were 
constructed of 2 x 2 hardware cloth. Three photocells (6.5 
cm apart, 5 cm from the floor) monitored activity in each 
unit. A microphone suspended from the top-center of each 
unit monitored vocalizations. Each unit was housed in a 
fan-ventilated, sound-attenuated chamber (BRS/LVE, model 
LEC-006) illuminated by a 20 W fluorescent light centered on 
the ceiling of the BRS/LVE chamber. Computer interface 
modules and data collection software (MED Associates, East 
Fairfield, VT) recorded vocalizations and photocell 
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interruptions. White noise masked extraneous environmental 
noises in the experimental room. 
Tonic immobility. Tonic immobility tests occurred in 
plastic tiobs (50 x 38 x 20 cm) lined with newspapers. White 
noise masked environmental noises. 
Procedure 
The experimental design for weight data obtained on PHD 
1 and 14 was a 4 (Dose) x 2 (Sex) x 2 (Age) factorial. The 
design for behavioral data was a 4 (Dose) x 2 (Sex) 
factorial. Age was not a factor in the latter design 
because each behavioral test was conducted at only one age 
for each chick. The design for the immunological portion of 
the experiment was a 2 (Dose) x 2 (Sex) factorial, because 
time constraints allowed assays for only 2 prenatal DFP 
groups. 
Incubation/Hatch. A 1-mm diameter hole was drilled 
adjacent to the airspace of each egg. A 0.5-cm square piece 
of surgical tape was placed over each access hole. All eggs 
were then placed into a temperature and humidity controlled 
incubator. Chick embryos (n=30 per injection group) 
received DFP (0, 50, 100, 200, 400, 800, 1600, or 3200 
Ug/kg; 0.9% sterile saline vehicle; volume=l ml/kg) injected 
into the airspace of eggs on E 11, the midpoint of 
incubation. Upon hatching chicks were weighed, banded for 
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identification, and housed in cages according to drug 
treatment group. 
Vocalizations and Activity. Locomotor behavior was 
evaluated on PHD 1. Individual chicks underwent a 5-min 
isolation period during which distress vocalizations (DVs) 
and photocell interruptions (activity) were monitored. 
Chicks were weighed prior to being returned to their home 
cages. 
Tonic Immobility. Defensive behavior was examined on 
PHD 14 using restraint-induced tonic immobility. This age 
was chosen because TI in younger chicks is not robust and 
previous data were available for this age (Gallup et al., 
1983; Hughes, 1982) . An experimenter who was blind to 
treatment conditions induced TI. A chick was quickly 
inverted, placed on its back, and physically restrained for 
15 seconds. A timer was started upon the experimenter's 
release of the chick. The criterion for a successful 
induction was 10 sec of immobility. If a subject did not 
meet this criterion, induction was attempted again (3 
attempts maximum) . Latency to the chick righting itself 
from this dorsally recumbent position was recorded (300 sec 
cutoff) by trained observers. Chicks were weighed prior to 
return to their home cages. 
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Immune Assays. On PHD 1 6 ,  2 days after the TI test, the 
chicks were sacrificed. Blood, thymus, and spleen were 
harvested to obtain leukocytes for a mitogenic stimulation 
assay. Sex was determined by confirmation of presence of 
the ovary or testes. Prenatal DFP effects on perinatal 
mitogen-induced lymphocyte proliferation were assayed by 
exposure of immune tissues to T-cell and B-cell mitogens. 
The mitogens used for immune assays were the T-cell mitogen 
concanavalin A (Con A), B-cell mitogen lipopolysaccharide 
(LPS) from Salmonella typhimurium and pokeweed mitogen (PWM) 
which stimulates B-cells and T-cells. The proliferation of 
lymphocytes in response to these mitogens was used to assess 
immunological function in previous studies (Cunnick et al., 
1994; Hughes et al., 1994a; Hughes et al., 1994b). 
Data were analyzed by Pearson chi-square or ANOVA and 
t-tests for planned comparisons. 
Results 
Hatch 
Prenatal DFP prevented hatches at doses higher than 200 
pg/kg (Figure 1). Pearson Chi Square analysis of hatch data 
indicated no significant difference in the number of live 
hatches at 0, 50, 100, and 200 ]ig/kg DFP (n = 19, 21, 23, 
19, respectively) and no significant sex differences 
(assiiming equal initial frequencies per group) . 
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Figure 1. Percent of eggs that hatched and chicks survived 
longer than 3 days as a function of prenatal DFP 
dose and sex. Embryos received 0, 50, 100, 200, 
400, 800, 1600, or 3200 yig/kg DFP injected into 
the airspace of the egg on Ell, the midpoint of 
embryogenesis. There were no hatches in the 
groups that received doses greater than 200 ug/kg 
DFP. 
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Weight 
Chicks that received prenatal DFP weighed less than 
controls at hatch (Figure 2). By PHD 14 this trend 
reversed; DFP groups weighed significantly more than 
controls. Analysis of the weight data revealed a 
significant main effect of Sex [F(1,73)=8.136,£=0.0057] and 
Age [F(l,73)=5382.184, £<0.0001], but not Dose. 
Additionally, there were significant interactions of Dose x 
Age [F{3, 73)=11.352, £<0.0001], Sex x Age [F(l, 73)=7.817, 
£=0.0067]. At hatch, female controls weighed significantly 
more than the DFP groups (0 > 50, 100, 200 ug/kg, g=0.0115; 
0.0141; 0.0376, respectively) as did males groups (0 > 50, 
100, 200 ]ig/kg, £=0.0052; 0.0005; 0.0003, respectively). By 
PHD 14, the female (50, 100, 200 > 0 pg/kg, g=0.0637; 
0.0028; 0.0034, respectively) and male (50, 100, 200 > 0 
Vig/kg, £=0.007; 0.0317; 0.0598, respectively) DFP chicks 
weighed significantly more than controls. 
Distress Vocalizations and Activity 
Prenatal DFP decreased DVs for females, but did not 
significantly alter DVs in males during the 5-min isolation 
period (Figure 3) . Due to positively skewed distributions, 
DV data were log-transformed prior to analysis. Analysis of 
log-transformed distress vocalization data revealed a 
significant interaction of Dose and Sex [F(3, 73)=3.076,£ 
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Figure 3. Mean vocalizations (+ and - SEM) during a 5-min 
isolation test on PHD 1 as a function of prenatal 
DFP dose and sex. Embryos received 0, 50, 100, 
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=0.0329); there were no significant main effects for Dose or 
Sex. Prenatal DFP reduced DVs at 50 pg/kg and increased DVs 
at 100 & 200 ]ig/kg DFP, but not significantly. Females that 
received 100 pg/kg vocalized less than females that received 
0, 50/ and 200 (£=0.0073; 0.0864; 0.0115, respectively). 
Males vocalized significantly more than females at 100 pg/kg 
DFP (£=0.0014). Analysis of activity data (Figure 4) 
indicated no significant differences for mean photocell 
interruptions between treatment groups during the 5-min 
isolation period. 
Tonic Immobility 
Prenatal DFP increased tonic immobility duration 
compared to control groups (Figure 5). Immobility data were 
log-transformed prior to analysis because they were 
positively skewed. Analysis of tonic immobility duration 
data showed a significant main effect of Dose [F(3, 
73)=3.594, £=0.0115] and interaction of Dose x Sex [F(3, 
73)=3.245, £=0.0269]; there was no significant main effect 
of Sex. There were no significant differences between sexes 
for mean tonic immobility duration among control groups. 
Prenatal DFP increased immobility duration in males at all 
doses compared to controls (50, 100, 200 > 0; £=0.0052; 
0.0115; 0.0083, respectively). Only females that received 
100 ug/kg showed increased immobility duration compared to 
controls (100 > 0, £=0.0115). Males exhibited 
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significantly longer tonic immobility duration than females 
only at 50 ug/kg DFP (g=0.034). 
Immune Assays 
Prenatal DFP increased LPS-induced blood lymphocyte 
proliferation and negated the sex difference exhibited in 
controls (Figure 6). Analysis of LPS-induced blood 
lymphocyte proliferation revealed main effects (at £ values 
> 0.05 & < 0.1) of Dose [F(l, 8)=3.592, £=0.0972] and Sex 
[F(l, 8)=4.413, £=0.0689]. Planned comparisons indicated 
significantly greater lymphocyte proliferation in males 
compared to females at 0 pg/kg DFP (£=0.0249) . Prenatal DFP 
produced significantly greater proliferation in females (200 
> 0 iig/kg; £=0.0243) which was not significantly different 
than that of males at 200 ug/kg DFP. There were no 
significant differences in PWM- or Con A-induced blood 
lymphocyte proliferation. Additionally, there were no 
significant differences between groups for mitogen-induced 
lymphocyte proliferation in spleen or thymus. 
Discussion 
Experiment 1 was designed to determine single exposure 
dose parameters for prenatal DFP exposure and to evaluate 
possible effects on perinatal responses. Doses that did not 
prevent hatches or produce morphological abnormalities would 
be used in subsequent experiments to assess more subtle 
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Figure 6. Mean blood stimulation index {+ and - SEM) as a 
function of prenatal DFP dose and sex. The B-
cell mitogen LPS induced lymphocyte 
proliferation in blood harvested on PHD 16. The 
blood stimulation index represents the ratio of 
lymphocytes in blood samples exposed to LPS and 
control samples. Embryos received 0, 50, 100, 
200 ^g/kg DFP injected into the airspace of the 
egg on Ell, the midpoint of embryogenesis. 
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behavioral effects of prenatal DFP exposure. Since 
sufficient numbers of chicks hatched at 200 pg/kg DFP and 
lesS/ behavioral and immunological effects of DFP exposure 
were examined. 
Hatch data indicated that the lethal dose for a single 
prenatal DFP exposure at the midpoint of embryogenesis in 
domestic fowl was between 200 and 400 pg/kg. Further 
research is required to more accurately determine the lethal 
dose and the LD50. However, the aim of this experiment was 
to determine a range of sub-lethal doses at which more 
subtle behavioral and immunological effects might occur. 
Prenatal DFP produced lower hatch weights at all doses 
compared to control animals. This relationship was reversed 
by PHD 14 when all DFP groups weighed significantly more 
than controls. The low hatch weight is consistent with the 
effects of many teratogens. Prenatal exposure to lead, 
cadmium, alcohol, nicotine, opiates, and cocaine reduces 
birth weight (Ali, Murthy, & Chandra, 1986; Middaugh, 
Lawrence, Randall, Favara, 1988). Weight gains associated 
with neurotoxin exposure have also been observed in humans. 
Children who received chronic lead exposure were more likely 
to be obese as young adults (Kim, Hu, Rotnitzky, Bellinger, 
& Needleman, 1995). 
A single prenatal DFP exposure differentially affected 
DVs in females and males. These data indicated that 
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prenatal DFP decreased DVs in females and increased DVs in 
males. Distress vocalizations vary as a function of stress 
or fear. Chicks (both isolated and with cohorts) placed 
into a novel environment similar to their ovm home cage emit 
more DVs than chicks that remain in their home cage and DVs 
continue to increase as environmental dissimilarity 
increases (Fullerton et al., 1959). Chicks that received 
handling before isolation emitted more DVs than chicks that 
were not handled (Sufka & Hughes, 1991). These data suggest 
that DVs vary in an inverted U-shaped function as fear 
increases (Sufka & Hughes, 1991). The biphasic pattern of 
fear-induced DVs makes it difficult to interpret these 
vocalization data. However, these data suggest that DVs may 
be sensitive to prenatal DFP exposure. 
The existing literature suggests that increased central 
cholinergic activity should produce decreased activity 
compared to controls. Although prenatal DFP tended to 
decrease activity for females there were no significant 
differences among treatment groups for either sex. 
Tonic immobility duration data were consistent with 
enhancement of TI by cholinergic agonists described in the 
existing literature (Gallup et al., 1983; Hennig et al., 
1988; Sanberg, 1983; Thompson et al., 1974; Woodruff et al., 
197 6). Prenatal DFP significantly increased tonic 
immobility duration in all 3 treatment groups in males but. 
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significantly increased immobility duration in females only 
at 100 vig/kg DFP. Although there was no significant main 
effect for sex, these data suggest that females might be 
less sensitive to a single prenatal DFP exposure compared to 
males. Prenatal exposure to 50 jig/kg DFP did not increase 
immobility duration of females but significantly increased 
duration for males. Prenatal DFP significantly increased 
immobility duration of both sexes at 100 pg/kg DFP. 
Immune data indicated sex differences in LPS-induced 
blood lymphocyte proliferation. Prenatal DFP (200 jig/kg) 
increased B-cell proliferation in females so that they were 
not significantly different from males. These data suggest 
a differential risk of immunological disregulation for 
females compared to males that may index greater 
susceptibility to autoimmune diseases. Experiment 1 
demonstrated significant behavioral and immunological 
consequences of a single prenatal DFP exposure and these 
effects are relatively durable. Prenatal DFP altered TI and 
immunological responses on PHD 14 and 16, respectively. The 
prenatal DFP effects are evident 26 days after the single 
exposure on E 11. The persistence of DFP effects on TI and 
immunological responses suggests that DFP may alter the 
development of regulatory processes in embryos and that the 
effects are relatively durable. 
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EXPERIMENT 2 
Because AChE deactivation by DFP is long-lasting, a 
potential exists for ciomulative effects of multiple DFP 
exposures. Therefore, several low-level exposures to DFP 
might have more profound developmental effects than a single 
exposure. Experiment 2 was designed to determine cumulative 
effects of repeated prenatal DFP exposures on perinatal 
behavioral and immune responses in chicks. Embryos received 
a single daily exposure to the nonfatal DFP doses in 
Experiment 1 on E 10-12, a period of rapid brain 
development. 
Method 
Subjects and Apparatus 
All subject (N=74) and apparatus characteristics were 
identical to Experiment 1. 
Procedure 
The experimental design for weight data obtained on PHD 
1 and 14 was a 4 (Dose) x 2 (Sex) x 2 (Age) factorial. The 
design for behavioral data was a 4 (Dose) x 2 (Sex) 
factorial. Age was not a factor because each behavioral 
test was conducted only once for each chick. A 2 (Dose) x 2 
(Sex) design was used for immunological data, because time 
constraints allowed assays for only 2 prenatal DFP groups. 
Diisopropyl fluorophosphate (0, 50, 100, or 200 ]ig/kg) was 
injected into the airspace of fertile eggs on 3 successive 
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days (E 10-12) at midpoint of incubation. Treatment groups 
were females that received 0 {n=13)/ 50 (n=13), 100 (n=6), 
or 200 (n=5) pg/kg DFP and males that received 0 (n=12), 50 
(n=7), 100 (n=12), or 200 (n=7) ug/kg DFP. All other 
procedures were identical to those described in Experiment 
1. Hatch data were evaluated by Pearson Chi-square 
analysis. All other data were analyzed by ANOVA and t-tests 
for planned comparisons. 
Results 
Hatch 
Repeated prenatal DFP exposure on E 10-12 reduced hatch 
success and survival, but did not disproportionately affect 
females or males (Figure 7). Analysis of hatch data 
indicated a dose-dependent decrease in live hatches as a 
function of Dose (X^ =9.28 6, g =0.024) . Although male 
hatches tended to be lower than females at 50 pg/kg and 
higher at 100 ]iq/kq, there were no significant sex 
differences. 
Weight 
Prenatal DFP produced decreased weight at hatch and 
increased weight on PHD 14 that depended on dose and sex 
(Figure 8) . Analysis of variance of weight data revealed a 
main effect of Dose [F(3,67)=6.189, £ = 0.0009], Age [F(l, 
67)=4420.5, £ < 0.0001], and interaction of Dose and Age 
[F(3, 67)=10.165, £ < 0.0001]. Prenatal DFP decreased hatch 
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weights of males, 0 > 100 and 200 ug/kg (£=0.0629; 0.0281, 
respectively), but not females. On PHD 14, weight of chicks 
that received 200 ^g/kg DFP was significantly greater than 
that of controls for males, (200 > 0 pg/kg (£=0.0013) and 
females (200 > 0 yg/kg; £=0.0042). 
Distress Vocalizations and Activity 
Repeated prenatal DFP exposure did not differentially 
affect DVs (Figure 9). Analysis of vocalization data 
revealed no significant effects of prenatal DFP. Although 
DFP increased DVs (at £ values > 0.05 & < 0.1) in females at 
50 ug/kg (50 > 0, £=0.06), ANOVA F test values revealed no 
significant main effects or interactions for these data. 
Prenatal DFP increased activity during isolation on PHD 
1 depending on dose and sex (Figure 10). Analysis of 
activity data indicated a main effect of Dose tF(3, 
67)=3.95, £ = 0.0118] and interaction of Dose and Sex [F(3, 
67)=4.972, £=0.0036]. There was no significant main effect 
of Sex. Females that received 100 ug/kg exhibited 
significantly more photocell interruptions than controls 
(100 > 0 pg/kg, £=0.0011) and the other DFP groups (100 > 50 
and 200 ug/kg, £=0.0009; 0.0071, respectively). There were 
no significant differences in activity of females between 
the 0, 50, and 200 ug/kg groups. Males that received 50 
pg/kg were significantly more active than controls (50 > 0 
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Figure 10. Mean photocell interruptions (+ and - SEM) 
during a 5-min isolation test on PHD 1 as a 
function of prenatal DFP dose and sex. Embryos 
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^g/kg, £=0.012) and the other DFP groups (50 > 100 and 200 
jig/kg, £=0.0533; 0.0317, respectively). There were no 
significant differences in activity of males between the 0, 
100, and 200 lag/kg DFP groups. 
Tonic Immobility 
Repeated prenatal DFP exposure increased tonic 
immobility duration of females but not males (Figure 11). 
Analysis of tonic immobility data indicated a main effect of 
Sex [F(l, 66)=4.479, £=0.0382], but no significant main 
effect of Dose or interaction of Sex and Dose. Females that 
received 100 ug/kg DFP remained immobile significantly 
longer than controls (100 > 0 pg/kg, £=0.0398). Immobility 
duration of females that received 50 and 200 ug/kg DFP was 
intermediate to that of controls and the 100 pg/kg group. 
Females that received 50 or 200 pg/kg DFP were not 
significantly different from either the 0 or 100 pg/kg DFP 
groups. There were no significant differences in immobility 
duration for males. 
Immune Assays 
Prenatal DFP decreased PWI-I-induced blood lymphocyte 
proliferation (Figure 12) . Analysis of blood lymphocyte 
proliferation data indicated a main effect (at £ values > 
0.05 & < 0.1) of Dose [F(l, 8)=4.492, £=0.067], but no 
significant main effect of Sex or interaction of Dose and 
Sex. 
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induced by brief physical restraint (15 sec) 
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Figure 12. Mean blood stimulation index {+ and - SEM) as a 
function of prenatal DFP dose and sex. The 
mitogen PWM induced lymphocyte proliferation in 
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Prenatal DFP increased LPS-induced lymphocyte proliferation 
in the thymus (Figure 13). Analysis of variance of 
lymphocyte proliferation revealed a main effect (at £ values 
> 0.05 & < 0.1) of Dose [F(l, 8)=4.024, £=0.0798). There 
were no significant main effect of Sex or interaction of 
Dose and Sex. 
Discussion 
Hatch data from Experiment 2 demonstrated cumulative 
effects of DFP exposure on E 10-12. Repeated prenatal DFP 
exposure reduced hatch success and survival. This outcome 
is in contrast to effects of a single exposure in Experiment 
1, where there were no significant differences between 
groups that received 200 ug/kg DFP or less. As in 
Experiment 1, prenatal DFP did not disproportionately affect 
mortality of males or females. 
Prenatal DFP produced effects on weight similar to 
those observed in Experiment 1. Hatch weights were reduced 
for males and unaffected for females. However, on PHD 14 
males and females that received 200 ug/kg DFP weighed 
significantly more than controls. These data are consistent 
with those obtained in Experiment 1 where prenatal DFP 
reduced hatch weights of all chicks compared to controls and 
this relationship was also reversed by PHD 14. 
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Figure 13. Mean thymus lymphocyte proliferation {+ and -
SEM) as a function of prenatal DFP dose and sex, 
The B-cell mitogen LPS induced lymphocyte 
proliferation in thymus harvested on PHD 16. 
Embryos received 0, 100, or 200 jig/kg DFP 
injected into the airspace of the egg on El0-12. 
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Activity data revealed a substantial dose-dependent increase 
in activity for each of the sexes. These data are in 
contrast with the results of Experiment 1 where a single 
prenatal DFP exposure did not significantly affect activity. 
Nor was it consistent with the literature on cholinergic 
agonists that describes decremental effects on locomotor 
behavior (Genty et al., 1985/ Ksir, 1978; Sanberg, 1983). 
In Experiment 2, repeated prenatal DFP exposure produced 
significant increased activity in males only at 50 ug/kg and 
in females only at 100 lag/kg DFP. The small number of males 
that received 50 ug/kg (n=7) and females that received 100 
Ug/kg DFP (n=6) might cause the means for these groups to be 
more susceptible to the influences of extreme activity 
counts of some individuals. The extensive variability in 
male 50 pg/kg and female 100 pg/kg DFP groups suggests an 
extreme influence of outliers on the means for these small 
groups. Other than the 2 groups discussed above, prenatal 
DFP administered on E 10-12 did not significantly affect 
activity in the second experiment. Emergence of DFP effects 
on activity (c.f.. Experiments 1 & 2) may require 
substantially greater exposure. 
Repeated prenatal DFP exposure differentially affected 
tonic immobility duration of males and females. The pattern 
of DFP effects was different than that of Experiment 1 in 
which repeated prenatal DFP increased TI at all doses for 
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males and at 100 yg/kg for females. There was a dose-
dependent increase in immobility duration for females, but 
not for males. Prenatal DFP decreased immobility duration 
of males, although not significantly. The DFP-induced 
increase in TI for females is consistent with the literature 
in which cholinergic agonists enhances TI. These data are 
also compatible with the proposition that females may be 
hyposensitive to DFP effects on TI compared to males. 
Repeated exposure to DFP could produce increased immobility 
duration in less sensitive females, while decreasing 
duration in males. Repeated prenatal DFP exposure might 
produce excessive cholinergic activity in males and thereby 
attenuate TI. Excessive cholinergic activity at 
neuromuscular synapses can desensitize postsynaptic 
receptors, functionally blocking neurotransmission (Feldman, 
et al., 1997; Taylor, 1980). Serotonergic agonists have 
shown similar effects on TI as those produced by DFP in 
Experiment 2. Boren et al. (1979) demonstrated that 
pargyline, a monoamine oxidase inhibitor (MA.OI), and 
tryptophan, a serotonin precursor, administered separately 
increased TI, but when given in combination attenuated TI. 
44 
EXPERIMENT 3 
Experiments 1 and 2 demonstrate that prenatal DFP 
exposure alters tonic immobility duration. Tonic immobility 
duration has been shovm to be mediated by central 
cholinergic mechanisms (Hughes, 1982; Thompson et al., 1974) 
and DFP deactivates AchE, thereby increasing cholinergic 
activity (Feldman et al., 1997; Rang et al., 1995). If 
increases in TI duration are mediated by prenatal DFP-
induced potentiation of cholinergic activity (Gallup et al., 
1983; Sanberg, 1983; Thompson et al., 1974), then a 
cholinergic antagonist should reverse or attenuate the 
effect. Scopolamine, a cholinergic antagonist that 
primarily blocks muscarinic receptors reduced TI (Hughes, 
1982; Thompson et al., 1974). Cholinergic agonists increase 
DVs (Sufka & Hughes, 1991) and TI (Gallup et al., 1983; 
Sanberg, 1983; Thompson et al., 1974), and decrease activity 
(Genty et al., 1985; Ksir, 1978; Sanberg, 1983). Therefore, 
scopolamine administered to chicks, 30 min prior behavioral 
assays should attenuate or reverse effects of prenatal DFP. 
Experiment 3 was designed to test this hypothesis, as well 
as evaluate DFP effects on hatch success and weight. 
Method 
Subjects and Apparatus 
All subject (N=117) and apparatus characteristics were 
identical to Experiments 1 and 2. 
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Procedure 
The design of this experiment was a 3 (prenatal DFP 
dose) X 3 (postnatal scopolamime dose [SCO]) factorial 
design for the behavioral tests. A 3 (prenatal DFP dose [0, 
n=45; 100, n=51; 200, n=22]) x 2 (Age, PHD 1 & 14) factorial 
design was used for weight data. Sex data were not 
available for analysis due to a technical error. 
Diisopropyl fluorophosphate (0, 100, or 200 ^g/kg; vol\ime=l 
ml/kg; ip) was injected into the airspace of fertile eggs on 
3 successive days (E 10-12) at midpoint of incubation. 
Thirty minutes prior to isolation and tonic immobility tests 
chicks received scopolamine hydrobromide (0.0, 0.5, & 1.5 
mg/kg). These scopolamine doses altered tonic immobility 
duration in a previous study (Hughes, 1982) . Immune 
responses were not evaluated. Treatment groups and the 
number of subjects per cell are represented in Table 1. 
Table 1. Treatment groups for Experiment 3. 
Scopolamine Dose [mg/kg] 
DFP Dose [iJg/kg] 0.0 0.5 1.5 
0 n=15 n=14 n=16 
100 n=14 n=18 
00 1—1 II d 
200 n=6 n=8 n=8 
other procedures were identical to those described in 
Experiment 1. Hatch data were evaluated by Pearson Chi-
square analysis. All other data were analyzed by ANOVA and 
t-tests for planned comparisons. 
Results 
Hatch 
Repeated prenatal DFP (200 pg/kg) reduced the number of 
chicks that hatched and survived longer than 3 days (Figure 
14). Chi square analysis indicated a significant effect of 
DFP on hatch success (X^= 35.429, g < 0.0001) . 
Weight 
There were no significant effects of repeated DFP on 
hatch weights or weights on PHD 14 (Figure 15). 
Distress Vocalizations and Activity 
Repeated prenatal DFP reduced DVs and scopolamine 
reversed this effect on a dose-dependent basis (Figure 16). 
Analysis of vocalization data indicated a significant main 
effect of DFP [F(2, 117)=4.269, £=0.0162]. There was no 
significant main effect of SCO or interaction of DFP and 
SCO. Prenatal DFP significantly reduced DVs compared to 
controls (100 < 0 pg/kg DFP, £=0.0076). Scopolamine 
produced a dose-dependent reversal of this effect. The DFP-
induced decrease in vocalizations was reversed by 1.5 mg/kg 
scopolamine (1.5 > 0.0 mg/kg, £=0.0098) but not by 0.5 mg/kg 
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repeated (3 exposures) prenatal DFP dose and age 
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Figure 16. Mean vocalizations (+ and - SEM) during a 5-min 
isolation test on PHD 1 as a function of 
prenatal DFP dose and postnatal scopolamine 
dose. Embryos received 0, 100, or 200 pg/kg DFP 
injected into the airspace of the egg on ElO-12. 
Chicks received 0.0, 0.5, or 1.5 mg/kg 
scopolamine (volume=l ml/kg; ip) 30 minutes 
before the behavioral test. 
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scopolamine. There were no significant effects of DFP or 
SCO on mean photocell interruptions (Figure 17). 
Tonic Immobility 
Postnatal scopolamine decreased tonic immobility duration as 
a function of DFP dose (Figure 18). Analysis of tonic 
immobility duration revealed a main effect (g values > 0.05 
& < 0.1) of SCO [F(2, 108)=2.747, £=0.0686], but no main 
effect of DFP. The main effect of SCO was qualified by the 
interaction (£ values > 0.05 & < 0.1) of DFP and SCO [F(4, 
108)=2.177, £=0.0763]. Scopolamine decreased tonic 
immobility duration of control chicks and those that 
received 100 pg/kg DFP (0.5 < 0.0 mg/kg scopolamine, 
£=0.0468; 0.0362, respectively), but did not reduce 
immobility duration in chicks that received 200 pg/kg 
prenatal DFP. 
Discussion 
Hatch data from Experiment 3 were consistent with data 
obtained in Experiment 2, in which 200 yg/kg DFP 
administered on E 10-12 significantly reduced hatch success. 
Repeated prenatal DFP exposure significantly decreased hatch 
success and survivability of chicks at 200 ug/kg DFP but did 
not at 100 pg/kg. 
Weight data did not indicate any differences due to 
prenatal DFP exposure. These data were not consistent with 
Experiment 1 and 2, in which prenatal DFP chicks weighed 
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Figure 17. Mean photocell interruptions {+ and - SEM) 
during a 5-min isolation test on PHD 1 as a 
function of prenatal DFP dose and postnatal 
scopolamine dose. Embryos received 0, 100, or 
200 ug/kg DFP injected into the airspace of the 
egg on ElO-12. Chicks received 0.0, 0.5, or 1.5 
mg/kg scopolamine (volume=l ml/kg; ip) 30 
minutes before the behavioral test. 
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Figure 18. Mean tonic immobility duration (+ and - SEM) 
induced by brief physical restraint (15 sec) 
during a 5-min test on PHD 14 as a function of 
prenatal DFP dose and postnatal scopolamine 
dose. Embryos received 0, 100, or 200 ug/kg DFP 
injected into the airspace of the egg on ElO-12. 
Chicks received 0.0, 0.5, or 1.5 mg/kg 
scopolamine {volume=l ml/kg; ip) 30 minutes 
before the behavioral test. 
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significantly more than controls on PHD 14. The lack of sex 
data may have masked potential DFP effects on weight in this 
experiment. 
Vocalization and activity data during the isolation 
test continued to vary across experiments. Prenatal DFP 
produced similar effects on DVs and activity in Experiments 
1 (single exposure) and 3 (3 exposures), but were in 
contrast to effects on these measures in Experiment 2 (3 
exposures). A single prenatal DFP exposure in Experiment 1 
significantly decreased DVs, but did not affect activity and 
in Experiment 2, 3 DFP exposures significantly increase 
activity, but had no effect on DVs. 
In Experiment 3 prenatal DFP on E 10-12 decreased DVs 
at the 100 pg/kg dose, but not at 200 ]ig/kg. Scopolamine 
(1.5 mg/kg) reversed this effect. The DFP effects on DVs 
were similar to DFP effects in Experiment 1, where a single 
DFP exposure reduced DVs in females 50 and 100 yg/kg, and in 
males only at 50 pg/kg. Prenatal DFP on E 10-12 did not 
significantly alter DVs in Experiment 2. Scopolamine, a 
cholinergic antagonist, reversed the DFP-induced reduction 
of DVs in Experiment 3. The attenuation of DFP effects on 
DVs by scopolamine suggests that the DFP-induced dose-
dependent reduction in DVs was due to increased cholinergic 
activity. 
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Effects of prenatal DFP on activity also varied across 
Experiments 1-3. A single DFP exposure in Experiment 1 and 
repeated DFP exposure on E 10-12 in Experiment 3 did not 
affect activity. Additionally, in Experiment 3, scopolamine 
administered 30 min before isolation did not affect 
activity. In Experiment 2, repeated DFP exposure (E 10-12) 
produced unexpected increases in activity. Activity, as 
measured herein, is evidently not very sensitive to 1 or 3 
exposures to prenatal DFP. 
Prenatal DFP significantly increased tonic immobility 
duration in Experiments 1 and 2. If the increased 
immobility duration was mediated by DFP-induced increases in 
cholinergic activity, the cholinergic antagonist scopolamine 
should reverse the effect. In Experiment 3, scopolamine 
reduced immobility duration of controls and chicks that 
received 100 pg/kg, but did not decrease immobility duration 
in chicks that received 200 lag/kg DFP. These data 
demonstrate the involvement of cholinergic mechanisms for 
DFP-induced effects on tonic immobility duration. Further, 
scopolamine's failure to decrease immobility duration in 
chicks that received 200 ug/kg DFP, is consistent with 
increased cholinergic activity due to prenatal DFP exposure. 
The lack of significant DFP effects might be due to a 
ceiling effect. Many test animals reached the 300 sec 
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criterion during the TI test. A number of animals reached 
criterion in Experiments 1 and 2, also. 
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EXPERIMENT 4 
Experiment 4 was designed to further characterize the 
nature of prenatal DFP-induced behavioral effects using a 
cholinergic agonist, physostigmine. Administration of 
physostigmine 30 min before behavioral tests was expected to 
increase cholinergic activity. Physostigmine, like DFP, 
increases cholinergic activity by inhibiting AChE, but is 
not as long-acting as DFP (Quenzer et al., 1997; Rang et 
al., 1995). According to the existing literature, 
physostigmine-induced increases in cholinergic activity 
should decrease activity (Genty, Faure, & Mills, 1985, Ksir, 
1978; Sanberg, 1983), and increase DVs and TI duration 
(Gallup et al., 1983; Thompson et al., 1974; Sanberg, 1983). 
Administration of physostigmine in Experiment 4 should have 
the same effects, unless cholinergic activity is excessive. 
If physostigmine administration produces excessive 
cholinergic activity opposite effects are possible 
(Carleton, 1983; Taylor, 1980). Prenatal DFP effects on 
hatch success and weight were also evaluated in Experiment 
4. 
Method 
Subjects and Apparatus 
All subject (N=92) and apparatus characteristics were 
identical to Experiments 1-3. 
57 
Procedure 
The experimental design for weight data was a 3 
(prenatal DFP dose) x 2 (sex) factorial. For the behavioral 
tests the experimental design was a 3 (prenatal DFP dose) x 
3 (postnatal physostigmine [PHY] dose) x 2 (Sex) factorial. 
Diisopropyl fluorophosphate (0, 150, or 200 pig/kg) was 
injected into the airspace of fertile eggs on 3 successive 
days (E 10-12) at midpoint of incubation. The 150 ug/kg DFP 
dose was chosen to maximize potential DFP effects and 
minimize hatch failure. Thirty minutes before the isolation 
and tonic immobility tests chicks received physostigmine 
hemisulfate (0.0, 0.25, & 0.5 mg/kg; volume=l ml/kg; ip). 
These physostigmine doses were chosen because they were 
comparable to doses used in the Thompson et al. (1974) 
study. As in Experiment 3, no immunological assays were 
conducted. Treatment groups and number of animals per cell 
are represented in Table 2. 
Chicks received handling and habituation to 
experimenters on PHD 14-17. During handling and 
habituation, a pair of chicks was removed from the home cage 
and transported to the weighing area in an opaque plastic 
container. Each chick was individually picked up, handled 
briefly, weighed, and returned to the plastic container. 
After both chicks had been handled and weighed, they were 
returned to the home cage. Handling and habituation to 
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Table 2. Treatment groups for Experiment 4. 
DFP Dose [pg/kg] 
Physostigmine Dose 
0.0 0.25 
[mg/kg] 
0.5 
Females 0 n=4 n=4 n=3 
150 n=4 n=4 n=6 
200 n=7 n=5 n=4 
Males 0 n=7 n=l n=7 
150 n=7 n=5 n=3 
200 n=7 n=5 n=8 
experimenters decreases TI duration (Gallup et al., 1983). 
Due to schedule constraints TI evaluation occurred on PHD 
18. In addition, the cutoff criterion for TI duration was 
increased to 600 sec (10 min). Chicks were handled and the 
cutoff for TI was changed to 600 sec to avoid possible 
ceiling effects. All other procedures were identical to 
those described in Experiment 1. Hatch data were evaluated 
by Pearson Chi-square analysis. All other data were 
analyzed by ANOVA and t-tests for planned comparisons. 
Results 
Hatch 
Repeated prenatal DFP exposure tended to reduce hatch 
and survival of chicks at 150 ]ig/kg, but this effect was not 
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significant (Figure 19). Analysis of hatch data indicated 
no significant differences in hatch success across groups as 
a function of DFP (X^=1.294, g=0.5237). 
Weight 
Females and males that received prenatal DFP weighed 
significantly more than controls by PHD 14 (Figure 20) . 
Analysis of weight data revealed a significant main effect 
of Sex [F(l, 87)=6.241, £=0.0145], DFP [F(2, 87)=13.226, 
£<0.0001], Age [F(l, 87)=5692,1, £<0.0001], but no 
significant main effect of DFP. The main effects were 
qualified by a significant interaction of DFP and Age [F(2, 
87)=19.278, £<0.0001]. On PHD 14, females (150 & 200 > 0 
lag/kg DFP, £=0.0008; 0,0008, respectively) and males (150 & 
200 > 0 vig/kg DFP, £=0.0002; 0.0001, respectively) that 
received prenatal DFP weighed significantly more than 
controls. Planned comparisons revealed significant sex 
differences for hatch weight only at 200 ]iq/kg DFP (males > 
females, £=0.0303). On PHD 14, males weighed more than 
females at all DFP doses, but approached significance only 
at 200 pg/kg DFP (£=0.0628). 
Distress Vocalizations and Activity 
Repeated prenatal DFP produced an increase in DVs that 
was dependent on postnatal PHY dose (Figure 21). There were 
no significant effects of sex, therefore data were analyzed 
as a 3 (prenatal DFP) x 3 (postnatal PHY) factorial. 
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Figure 19. Percent of eggs that hatched and chicks survived 
longer than 3 days as a function of repeated (3 
exposures) prenatal DFP dose and sex. Embryos 
received 0, 150, or 200 ug/kg DFP injected into 
the airspace of the egg on ElO-12. 
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Figure 20. Mean body weight {+ and - SEM) as a function 
of repeated (3 exposures) prenatal DFP dose 
and age (PHD 1 & 14). Embryos received 0, 
150, or 200 lag/kg DFP injected into the 
airspace of the egg on ElO-12. 
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Figure 21. Mean vocalizations (+ and - SEM) during a 5-min 
isolation test on PHD 1 as a function of 
prenatal DFP dose and postnatal physostigmine 
dose. Embryos received 0, 150, or 200 pg/kg DFP 
injected into the airspace of the egg on ElO-12. 
Chicks received 0.0, 0.25, or 0.5 mg/kg 
physostigmine {volume=l ml/kg; ip) 30 minutes 
before the behavioral test. 
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Analysis of vocalization data indicated a significant 
interaction of DFP and PHY [F{4, 83)=2.938, p=0.0252]. 
Physostigmine tended to decrease DVs at 0 and 200 ug/kg DFP, 
but not significantly. At 150 ug/kg DFP, 0.25 mg/kg PHY 
significantly increased DVs compared to chicks that received 
0.0 or 0.5 mg/kg PHY (0.25 > 0.0 and 0.5, £=0.0222; 0.0006, 
respectively). There were no significant effects of DFP or 
PHY on photocell interruptions (Figure 22) during the 5-min 
isolation period. 
Tonic Immobility 
Postnatal physostigmine increased tonic immobility 
duration depending on sex and prenatal DFP dose (Figure 23) . 
Analysis of tonic immobility duration revealed a significant 
main effect of DFP [F(2, 73)=3.977. £=0.0229], interaction 
(at £ value > 0.5 & < 0.1) of DFP and PHY [F(4, 73)=2.341, 
£=0.0629], and interaction of DFP, PHY, and Sex [F(4, 
73)=3.007, £=0.0236], Prenatal DFP significantly increased 
immobility duration in females (150 & 200 > 0 ug/kg DFP, 
£=0.0095; 0.0574, respectively). Physostigmine administered 
30 min before the tonic immobility test significantly 
increased immobility duration in chicks that received 0 
]ig/kg DFP (0.5 > 0.0 mg/kg physostigmine, £=0.0169). There 
were no significant differences in TI duration between male 
treatment groups. 
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Figure 22. Mean photocell interruptions (+ and - SEM) 
during a 5-iain isolation test on PHD 1 as a 
function of prenatal DFP dose and postnatal 
physostigmine dose. Embryos received 0, 150, or 
200 ]ig/kg DFP injected into the airspace of the 
egg on ElO-12. Chicks received 0.0, 0.25, or 
0.5 mg/kg physostigmine {volume=l ml/kg; ip) 30 
minutes before the behavioral test. 
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Figure 23. Mean tonic immobility duration (+ and - SEM) 
induced by brief physical restraint (15 sec) 
during a 10-min test on PHD 18 as a function of 
prenatal DFP dose, postnatal physostigmine dose, 
and sex. Embryos received 0, 150, or 200 pg/kg 
DFP injected into the airspace of the egg on 
ElO-12. Chicks received 0.0, 0.25, or 0.5 mg/kg 
physostigmine {volume=l ml/kg; ip) 30 minutes 
before the behavioral test. 
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Discussion 
Prenatal DFP did not significantly decrease hatch success 
and survival in Experiment 4. These data were in contrast 
with Experiments 2 and 3 in which DFP on E 10-12 adversely 
affected hatch success. The basis of this discrepancy is 
unknown. 
Prenatal DFP did not affect hatch weight of chicks. 
However, on PHD 14 chicks that received prenatal DFP weighed 
significantly more than controls. Prenatal DFP effects on 
weight at PHD 14 in Experiment 4 are consistent with data 
from Experiments 1 and 2 in which DFP groups weighed 
significantly more than controls at that same age. 
The TI data support predictions made for prenatal DFP 
and postnatal phsyostigmine effects in females. Prenatal 
DFP (3 exposures) significantly increased TI duration for 
females but not males. These results were similar to 
Experiment 2, in which 3 prenatal DFP exposures also 
significantly increased TI in females and did not affect 
males. The TI effects of 3 DFP exposures in Experiments 2 
and 4 are in contrast to effects in Experiment 1 wherein, a 
single prenatal DFP exposure increased TI in males at all 
doses and in females at only the intermediate DFP dose. 
Physostigmine enhanced TI in female chicks that received 0 
Vig/kg DFP. Physostigmine-induced potentiation of 
cholinergic activity produced a mean immobility duration 
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similar to that of chicks that received 150 and 200 ug/kg 
DFP. 
Attempts to avoid ceiling effects via increased 
handling and 600 sec criterion for TI were not effective. 
The experimenter that induced TI was not involved in 
handling of chicks prior to testing. Predatory encounters 
increase TI duration (Gallup, 1977) . Exposure to the novel 
experimenter as a predator may have produced similar 
effects. The TI data demonstrate that prenatal DFP 
enhancement of TI in females endures at least through PHD 
18. The persistence of DFP effects suggests that prenatal 
DFP effects may be developmental rather than transient 
changes in cholinergic activity. 
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GENERAL DISCUSSION 
Organophosphate compounds, potent AChE inhibitors, are 
widely used as agricultural pesticides (Mearns, Dunn, & 
Lees-Haley, 1994; Michalek & Pintor, 1990; Overstreet & 
Schiller, 1992). Little is known of possible perinatal 
consequences of prenatal OP exposure. The present series of 
experiments was designed to evaluate perinatal behavioral 
and immunological effects of prenatal exposure to DFP, an 
OP. 
Prenatal DFP reduced hatch weight in Experiments 1 and 
2, but had no significant effects on hatch weight in 
Experiments 3 and 4. However, in Experiments 1, 2, and 4, 
DFP chicks weighed significantly more than controls on PHD 
14. These data suggest that prenatal DFP altered either 
metabolism or feeding behavior in chicks. The DFP-induced 
low hatch weight in Experiments 1 (single exposure) and 2 (3 
exposures) are consistent with the effects of various 
teratogens. Prenatal DFP did not significantly reduce hatch 
weights in Experiments 3 and 4. The reason for this 
discrepancy is unknown. Prenatal exposure to lead, alcohol, 
nicotine, opiates, and cocaine reduces birth weight (Ali et 
al., 1986; Middaugh et al., 1988). 
Prenatal DFP-induced weight gains by PHD 14 were 
observed in Experiments 1, 2, and 4. Similar weight gains 
associated with neurotoxin exposure have been observed in 
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humans. Children who received chronic lead exposure were 
more likely to be obese as young adults (Kim, Hu, Rotnitzky, 
Bellinger, & Needleman, 1995). It is possible that current 
weight data reflect DFP-induced, cholinergically mediated 
effects. Prenatal DFP effects on body weight are also 
consistent with effects of hyperinsulinemia on body weight. 
Ventromedial hypothalamic (VMH) lesions cause obesity and 
hyperphagia in rats (Brobeck, Tepperman, & Long, 1943; 
Hetherington & Ranson, 1940). Hustvedt & Lovo (1972; cited 
in Pinel, 1997) demonstrated that VMH lesion-induced obesity 
and hyperphagia were due to elevated insulin levels. The 
pancreas secretes insulin in response to ACh released from 
parasympathetic neurons of the vagus nerve. Sawchenko, Eng, 
Gold, & Simson (1977; cited in Pinel, 1997) eliminated 
obesity and hyperphagia in VMH lesioned animals by severing 
the vagus nerve. Elevated blood insulin concentrations 
triggers the storage of nutrients as fat in adipose tissue. 
Inhibition of AChE by DFP increases ACh activity in the 
parasympathetic nervous system. The increased weight gain 
by DFP groups through PHD 14 in Experiments 1, 2, and 4, is 
consistent with the interpretation that prenatal DFP 
exposure increased cholinergic activity. 
The data from the current study suggest that DVs 
emitted during a 5-minute isolation period on PHD 1 may be 
sensitive to cholinergic manipulation. A single prenatal 
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DFP exposure differentially affected DVs of females and 
males in Experiment 1, but there were no significant sex 
differences in Experiments 2-4 (3 exposures). Distress 
vocalizations are an index of fear and vary in an inverted 
U-shaped fashion as fear increases (Fullerton et al., 1959; 
Sufka & Hughes, 1991) . In Experiments 1 (a single exposure) 
and 3 (3 exposures), 100 ug/kg DFP reduced DVs. Also, in 
Experiment 3, 1.5 mg/kg scopolamine administered 30 min 
before isolation reversed the DFP effect. Prenatal DFP on E 
10-12 did not significantly affect DVs in Experiment 2. 
Although there were no significant effects of DFP on E 10-12 
in Experiment 4, physostigmine, a cholinergic agonist, 
produced biphasic effects on DVs at 150 ug/kg DFP. Females 
that received 0.25 mg/kg emitted significantly more DVs than 
controls and 0.5 physostgmine tended to decrease DVs 
compared to controls, but not significantly. These data 
tend to support the proposition that DVs are sensitive to 
cholinergic manipulation in young domestic fowl. The nature 
of stress effects (Fullerton et al., 1959; Sufka & Hughes, 
1991) and drug dose (Carlton, 1983) on DVs, both vary in an 
inverted U-shaped fashion, may be factors contributing to 
the variability of vocalization data in this study. More 
consistent prenatal DFP effects on DVs may require different 
exposure parameters such as more than 3 exposures at 
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different doses, embryonic ages, and/or an evaluation 
session longer than 5 min. 
The existing literature regarding cholinergic effects 
on activity suggested that cholinergic agonists would 
decrease and antagonists increase activity in chicks. The 
data collected (concurrently with DVs) in this study during 
the 5-iain isolation period on PHD 1 did not reveal 
consistent DFP effects on the activity measure. In 
Experiment 1, a single DFP exposure at the midpoint of 
embryogenesis tended to decrease activity in females and 
increase activity in males, but neither significantly. In 
Experiments 3 and 4, repeated DFP on E 10-12 did not affect 
activity as did postnatal scopolamine and physostigmine, 
respectively. In Experiment 2, prenatal DFP on E 10-12 
significantly increased activity in males at 50 \iq/kg and 
females at 100 ^g/kg. However, the substantial variability 
in males at 50 pg/kg and females at 100 lag/kg DFP suggests 
the influence of outliers. The relatively small number of 
subjects in each group (n=7 and 6, respectively) might 
render the means for groups more susceptible to extreme 
activity counts. As with DVs more consistent prenatal DFP 
effects on activity may require different exposure and 
measurement parameters. Additionally, isolation-induced 
stress decreases activity. Activity levels may have been 
reduced by isolation stress and the low baseline activity 
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levels may have prevented emergence of prenatal DFP-induced 
effects. 
The current study demonstrated prenatal DFP effects on 
tonic immobility at PHD 14 and 18 in chicks and indicate 
that these effects are mediated by increased cholinergic 
activity. Further, DFP effects on TI differentially 
affected females and males. The TI response is considered 
an adaptive anti-predatory response (Ratner, 1977) and 
deviations from baseline responses might put the animal at 
greater risk. The TI data were collected on PHD 14 in 
Experiments 1-3 and in Experiment 4 on PHD 18. In 
Experiment 1, a single prenatal DFP exposure at midpoint of 
embryogenesis significantly increased TI duration in males 
at 50, 100, and 200 ug/kg doses and females at 100 jig/kg 
DFP. In Experiment 2, DFP exposure on E 10-12 significantly 
enhanced TI at 100 ug/kg in females and tended to decrease 
TI in males, but not significantly. Prenatal DFP on E 10-12 
did not significantly increase TI duration in Experiment 3. 
However, the interaction of postnatal scopolamine, a 
cholinergic antagonist, with prenatal DFP suggests that DFP 
altered cholinergic activity at 200 ug/kg DFP. Scopolamine 
(0.5 mg/kg) significantly reduced TI in controls and the 100 
lig/kg DFP group, but did not attenuate TI at 200 pg/kg. 
These data suggest that DFP effects on TI were due to 
increased cholinergic activity. In Experiment 4, DFP on E 
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10-12 significantly increased TI in females at 150 and 200 
]jg/kg, but did not significantly affect males. 
Physostigmine (0.5 mg/kg), a cholinergic agonist/ 
significantly increased TI in females that received 0 yig/kg 
DFP, producing TI duration similar to that of females at 150 
and 200 ug/kg DFP. 
In Experiment 1, a single prenatal DFP exposure 
produced a robust TI increase in males at 50 ng/kg, but 
females required 100 ug/kg to significantly enhance TI. 
These data suggest that females may be less sensitive to 
DFP-induced TI effects. Results from Experiment 2, in which 
embryos received 3 DFP exposures, appear to contradict a 
female hyposensitivity hypothesis. However, prenatal DFP 
produced dose-dependent TI increases at 50 and 100 pg/kg in 
females, suggesting a more robust effect at 50 yig/kg. 
Similarly in Experiment 4, DFP on E 10-12 produce robust TI 
increases in females, but had no significant effect on 
males. The absence of significant TI increases in males 
could be consistent with greater sensitivity to the 
cholinergic effects of DFP compared to females. Excessive 
ACh at neuromuscular junctions can prevent repolarization of 
the postsynaptic membrane and functionally block 
neurotransmission (Taylor, 1980). Increased cholinergic 
activity increases TI, but if excessive ACh blocked 
neurotransmission it might attenuate TI duration. The Boren 
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et al. study (1979) demonstrated that modest increases in 5-
HT can increase and excessive 5-HT can decrease TI. When 
administered individually, pargyline, a MAOI, and 
tryptophan, a serotonin precursor, increase 5-HT and enhance 
TI. However, when given in combination these serotonergic 
agonists decreased immobility duration and pretreatment with 
p-chlorophenylalanine, a 5-HT antagonist prevented the 
pargyline + tryptophan attenuation of TI. A similar 
phenomenon in the cholinergic system might explain the 
robust TI effect in males due to a single exposure in 
Experiment 1 and the lack of TI in males after 3 prenatal 
DFP exposures in Experiments 2 and 4. A single DFP exposure 
(Experiment 1) may moderately increase cholinergic activity 
and enhance TI, while 3 exposures (Experiments 2-4) might 
produce excessive cholinergic increases, which may attenuate 
TI. 
Prenatal DFP differentially altered mitogen-induced 
lymphocyte proliferation in the current study. In 
Experiment 1, a single prenatal DFP exposure at midpoint of 
embryogenesis, produced sex- and dose-dependent increases in 
LPS-induced blood lymphocyte proliferation. At 0 pg/kg DFP, 
lymphocyte proliferation in females was significantly less 
than males. Prenatal DFP, 200 jig/kg, increased lymphocyte 
proliferation in females, but not males, and abolished the 
sex difference observed at 0 iig/kg. The mitogen LPS, 
75 
stimulates proliferation of B-cells. In Experiment 2, 
prenatal DFP on E 10-12 altered lymphocyte proliferation in 
blood and the thymus. Prenatal DFP decreased PWM-induced 
blood lymphocyte proliferation in females and males. 
Pokeweed mitogen stimulates both B- and T-cells. Although 
DFP alterations in blood lymphocyte proliferation were 
induced by different mitogens in Experiments 1 (LPS) and 2 
(PWM) , both stimulate B-cells. However, PWM also stimulates 
T-cells. Because PWM affects both B- and T-cells, 
additional assays are required to determine whether the 
prenatal DFP alteration of PWM-induced lymphocyte 
proliferation reflects changes in B-cell populations, T-cell 
populations, or both. 
The LPS-induced B-cell proliferation in the thymus was 
increased by prenatal DFP on E 10-12. Normally, not many B-
cells are present in the thymus. These data might indicate 
increased B-cell function or inappropriate homing of B-cells 
to the thymus. Flow cytometry assays could determine 
whether thymus B-cell populations are actually enhanced or 
whether the response reflects enhanced functioning of B-
cells. 
Immune data from the current study suggest that B-cell 
proliferation in blood was increased by a single DFP 
exposure and B- and/or T-cell proliferation is decreased by 
3 exposures at the midpoint of embryogenesis. Disturbances 
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in baseline immune responses may be maladaptive. Deficient 
immune responses might put an animal at greater risk of 
infectious disease and excessive responses might increase 
risk of autoimmune diseases. 
The results of the current study demonstrated that 
prenatal DFP exposure altered weight gain, hatch success, 
perinatal behavior, and immunoreactivity in young domestic 
fowl. Further, the data suggest that prenatal DFP-induced 
TI effects were a result of increased cholinergic activity. 
Prenatal DFP effects may be due to irreversible deactivation 
of embryonic AChE which produced a relatively permanent (up 
to 27 days) increase in ACh activity. It is also possible 
that more than 4 weeks are required for AChE synthesis to 
restore AChE concentrations to normal levels. Chicks tested 
later than PHD 18 might exhibit normal responses for 
measures evaluated in this study. However, prenatal DFP 
might induce permanent changes in the development of the 
regulatory mechanisms for these responses. Prenatal DFP 
might permanently reduce AChE concentrations, which would 
increase synaptic ACh concentrations. The TI data are 
consistent with the literature describing effects of 
cholinergic agonists and antagonists on duration of the 
response (Hicks, 1976; Hennig et al., 1988 Hughes, 1982; 
Sanberg, 1983; Sanberg et al., 1981; Thompson et al., 1974). 
Vocalization and activity data did not reveal clear-cut 
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effects of prenatal DFP. More consistent effects on DVs and 
activity might require more than 3 exposures or alteration 
of other exposure parameters. 
The current study demonstrated that DFP at midpoint of 
embryogenesis significantly altered hatch success, weight 
gain, DVs, activity, tonic immobility, and immune responses. 
The baseline responses for these measures, by definition, 
are adaptive. Therefore, deviations from the baseline are 
abnormal, and might compromise survival. Further, 
consequences of prenatal DFP exposure persist into the third 
week of postnatal life in chickens. Prenatal DFP altered 
weight gain at PHD 14, TI at PHD 14 and 18, and immune 
responses on PHD 16, up to 27 days after exposure. Weight 
gain, TI, and immune responses were the most reliable 
correlates of prenatal DFP. The TI data suggest that 
prenatal DFP, a potent AChE inhibitor, produced increased 
cholinergic activity that persists at least through PHD 18. 
Under the conditions of this study, DVs and activity were 
not reliable indices of prenatal DFP exposure. Different 
doses, critical periods, and patterns of exposure might 
reveal greater effects on DVs and activity. These factors 
and other processes sensitive to cholinergic manipulation 
(e.g., learning and memory) should be investigated in future 
research. 
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